Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
20.09
0.27 (1.36%)
At close: Aug 15, 2025, 3:59 PM
19.70
-1.94%
After-hours: Aug 15, 2025, 06:46 PM EDT

Castle Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
119.71M 98.84M 122.95M 329.63M
Short-Term Investments
173.42M 144.26M 135.68M n/a
Long-Term Investments
n/a n/a 1.09M 1.31M
Other Long-Term Assets
2.15M 2.63M -25.58M 3.02M
Receivables
51.22M 38.3M 23.48M 17.28M
Inventory
8.13M 7.94M 3.98M 2.02M
Other Current Assets
7.67M 6.29M 6.21M 4.81M
Total Current Assets
360.15M 295.63M 292.29M 353.74M
Property-Plant & Equipment
62.71M 37.74M 26.5M 16.88M
Goodwill & Intangibles
106.23M 117.33M 126.35M 88.92M
Total Long-Term Assets
171.08M 157.71M 155.04M 108.83M
Total Assets
531.24M 453.34M 447.33M 462.57M
Account Payables
6.9M 10.27M 4.73M 2.55M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
278K n/a 1.78M 1.18M
Other Current Liabilities
774K 30.69M 23.9M 15.73M
Total Current Liabilities
49.39M 47.67M 36.13M 24.89M
Long-Term Debt
9.74M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 90K 18.41M
Total Long-Term Liabilities
26.01M 14.4M 12.05M 25.95M
Total Liabilities
75.4M 62.07M 48.18M 50.83M
Total Debt
26.34M 15.34M 13.31M 8.08M
Common Stock
28K 27K 27K 25K
Retained Earnings
-200.13M -218.37M -160.91M -93.77M
Comprehensive Income
230K 136K -381K n/a
Shareholders Equity
455.83M 391.27M 399.15M 411.74M
Total Investments
173.42M 144.26M 135.68M 1.31M